Kimura Yasuhiro, Hamatani Sayo, Matsumoto Kazuki, Shimizu Eiji
Department of Welfare Psychology, Faculty of Welfare, Fukushima College, Fukushima, Japan.
Research Fellow of Japan Society for the Promotion of Science, Japan.
Case Rep Psychiatry. 2020 Jul 14;2020:3892024. doi: 10.1155/2020/3892024. eCollection 2020.
Bipolar II disorder is a recurrent mental health disorder characterized by alternating hypomanic and depressive episodes. Providing cognitive behavioral therapy (CBT) as an adjuvant to pharmacotherapy can reduce the recurrence rate of bipolar disorder. It has not been examined whether CBT can be started during a depressive episode in patients with bipolar II disorder; however, the use of CBT during the remission period has been demonstrated to reduce recurrence. The current study is a case report involving three Japanese patients with bipolar II disorder, who started CBT during the depressive phase after a hypomanic episode was stabilized by pharmacotherapy. All patients experienced excessively positive thinking one week apart and were able to choose behaviors that would stabilize bipolar mood by observing its precursors. After intervention, patients' bipolar mood according to the Internal State Scale (ISS) and the Beck Depression Inventory-II (BDI-II) was improved. Our findings suggested that providing CBT to patients with bipolar II disorder during depressive episodes as an adjunct to pharmacotherapy is feasible.
双相II型障碍是一种复发性心理健康障碍，其特征为交替出现轻躁狂和抑郁发作。提供认知行为疗法（CBT）作为药物治疗的辅助手段可降低双相障碍的复发率。尚未研究CBT是否可在双相II型障碍患者的抑郁发作期间开始；然而，已证明在缓解期使用CBT可减少复发。本研究是一项病例报告，涉及三名日本双相II型障碍患者，他们在轻躁狂发作通过药物治疗稳定后，于抑郁期开始接受CBT。所有患者相隔一周均经历了过度积极的思维，并能够通过观察双相情绪的先兆来选择可稳定双相情绪的行为。干预后，根据内部状态量表（ISS）和贝克抑郁量表第二版（BDI-II）评估，患者的双相情绪得到改善。我们的研究结果表明，在抑郁发作期间为双相II型障碍患者提供CBT作为药物治疗的辅助手段是可行的。
